Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.00    -0.50 (-0.06%)
Bid:
845.50
Ask:
848.00
Spread: 2.50 (0.296%)
Market Cap: £977.83m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

6 Sep 2016 07:00

RNS Number : 0050J
Kainos Group plc
06 September 2016
 

 

ANNOUNCEMENT

6 September 2016

 

Kainos Group plc

("Kainos" or "the Group")

Trading Update

 

- Group maintains guidance for current year -

 

Kainos Group plc (KNOS), a leading UK-based provider of IT, consulting and software solutions, today issues a trading update for the period from 1 April 2016 to 31 August 2016.

 

In the Digital Services division, the Group is experiencing good growth in the public sector. Demand from central and regional government clients continues to strengthen, with notable new contract wins at the National Offender Management Service and the Home Office.

 

Demand for WorkSmart services is strong in the UK and mainland Europe, where the Group has added a number of new enterprise clients, including Tullett Prebon Group Limited. Take-up of the Group's SaaS-based automated testing product, Smart, is solid and the Group continues to invest in both product development and sales and marketing for Smart.

 

The Evolve division continues to make progress with its Integrated Care SaaS platform and has signed a five-year subscription agreement with Hygieia to use Evolve to power its insulin therapy navigation application which aims to help diabetics systematically manage their changing insulin requirements. In the UK, the Evolve for iPad™ offering, which allows clinicians to access electronic patient records on the move, is now in live operation at the South East Coast Ambulance Service. Market conditions in the NHS remain challenging, with limited additional funding to drive demand.

 

Although the outcome of the UK's referendum on Europe ('Brexit') brings with it some uncertainties, the Group continues to see immediate opportunities for growth.

 

Kainos has a robust balance sheet with strong reserves, no debt and strong cash generation, as well as a growing level of recurring revenue. The Group expects results for the full year to be in line with market expectations.

 

 

 

 

-ENDS-

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Brian Gannon, SVP Corporate Development

 

Investec Bank plc +44 20 7597 5970

Dominic Emery/Sebastian Lawrence

Patrick Robb/Matt Lewis

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon/Chris Lane

 

About Kainos

Kainos is a UK-based provider of IT services, consulting and software solutions. It specialises across multiple sectors in the development of digital technology solutions, including software design and agile software development. The Group's Evolve Electronic Medical Records (EMR) product provides a market-leading comprehensive suite of digital services to healthcare providers such as hospitals and community care organisations. Kainos has also developed an automated testing product, Smart, to complement its Workday implementation services.

 

Kainos Group plc (KNOS) is listed on the main market of the London Stock Exchange. At 31 March 2016, it had almost 800 staff working in eight offices in the USA, UK, Ireland, Poland and the Netherlands.

 

For further information please visit the company website: https://www.kainos.com/

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLAMFTMBBMBFF
Date   Source Headline
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSCapital Markets Event
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 202511:08 amRNSDirector Declaration
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20253:04 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSConfirmation of Board Changes
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20251:07 pmRNSResults of Annual General Meeting
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNS-RAcquisition in Canada of Davis Pierrynowski Ltd
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 202510:58 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTrading Statement
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.